These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11444762)

  • 21. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
    Emslie GJ; Ryan ND; Wagner KD
    J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalizability of antidepressant efficacy trials.
    Zimmerman M; Posternak MA; Chelminski I
    Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653
    [No Abstract]   [Full Text] [Related]  

  • 23. Models of antidepressant action.
    Berman RM; Charney DS
    J Clin Psychiatry; 1999; 60 Suppl 14():16-20; discussion 31-5. PubMed ID: 10408421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined antidepressants: clinical experience.
    Rojo JE; Ros S; Agüera L; de la Gándara J; de Pedro JM
    Acta Psychiatr Scand Suppl; 2005; (428):25-31, 36. PubMed ID: 16307617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment recommendations versus treatment realities: recognizing the rift and understanding the consequences.
    Frank E; Judge R
    J Clin Psychiatry; 2001; 62 Suppl 22():10-5. PubMed ID: 11599642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Target symptoms in the utilization of antidepressants].
    Tatarelli R; Girardi P; Vella G
    Encephale; 1984; 10(1):29-32. PubMed ID: 6376067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
    Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
    J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To combine or not to combine? A literature review of antidepressant combination therapy.
    Dodd S; Horgan D; Malhi GS; Berk M
    J Affect Disord; 2005 Dec; 89(1-3):1-11. PubMed ID: 16169088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.
    Santen G; Danhof M; Della Pasqua O
    J Psychiatr Res; 2008 Oct; 42(14):1189-97. PubMed ID: 18353370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of clinical and psychological methods in estimating antidepressants efficacy in treatment of depression (preliminary report)].
    Puzyński S; Koszewska I; Habrat E; Fornal S; Bzinkowska D; Gradzka D; Kalinowski A; Swiecicki Ł; Torbiński J
    Psychiatr Pol; 2002; 36(2):225-38. PubMed ID: 12043041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset, time course and trajectories of improvement with antidepressants.
    Lam RW
    Eur Neuropsychopharmacol; 2012; 22 Suppl 3():S492-8. PubMed ID: 22959114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?
    Mulsant BH; Houck PR; Gildengers AG; Andreescu C; Dew MA; Pollock BG; Miller MD; Stack JA; Mazumdar S; Reynolds CF
    J Clin Psychopharmacol; 2006 Apr; 26(2):113-20. PubMed ID: 16633138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
    Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.